2012
DOI: 10.1371/journal.pone.0042653
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression

Abstract: We have previously shown that human prostate cancer cells are capable of acquiring malignant attributes through interaction with stromal cells in the tumor microenvironment, while the interacting stromal cells can also become affected with both phenotypic and genotypic alterations. This study used a co-culture model to investigate the mechanism underlying the co-evolution of cancer and stromal cells. Red fluorescent androgen-dependent LNCaP prostate cancer cells were cultured with a matched pair of normal and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
65
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(72 citation statements)
references
References 44 publications
(78 reference statements)
6
65
1
Order By: Relevance
“…Growing in vitro (Busund et al 2002, 2003; Shabo et al 2015; Wei et al 2014), in vivo (Powell et al 2011; Silk et al 2013), and clinical (LaBerge et al 2017; Lazova et al 2013; Yilmaz et al 2005) data indicate that this process occurs in solid tumors and may play a significant role in clinical tumor progression. Moreover, this process generates malignant cell clones (hybrids) with reduced susceptibility to oncological treatments (Carloni et al 2013; Nagler et al 2011; Wang et al 2012; Yang et al 2010). …”
Section: Discussionmentioning
confidence: 99%
“…Growing in vitro (Busund et al 2002, 2003; Shabo et al 2015; Wei et al 2014), in vivo (Powell et al 2011; Silk et al 2013), and clinical (LaBerge et al 2017; Lazova et al 2013; Yilmaz et al 2005) data indicate that this process occurs in solid tumors and may play a significant role in clinical tumor progression. Moreover, this process generates malignant cell clones (hybrids) with reduced susceptibility to oncological treatments (Carloni et al 2013; Nagler et al 2011; Wang et al 2012; Yang et al 2010). …”
Section: Discussionmentioning
confidence: 99%
“…Fusion of tumor cells with hematopoietic or myeloid cells has been detected both in vitro and in vivo (19,20). More recently, myofibroblasts have emerged as a new fusion partner for osteosarcoma or prostate cancer cells (16,21). In addition, we detected CD68-positive tumor cells in the NFATc1-positive breast tumor specimens ( Fig.…”
Section: Identification Of Nfatc1-positive Tumor Cells In Human Carcimentioning
confidence: 57%
“…Some cells might experience growth arrest and cell death (38)(39)(40), whereas others might exhibit increased malignancy (9,16), depending on their parental cell types and the tumor microenvironment. Identification and analysis of bona fide fused cells positive for NFATc1 expression in vivo will be necessary to validate a role for NFATc1 in tumor progression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, MSCs were able to home to C4-2B xenograft tumors and enhance Wnt signaling activity [68]. Using a co-culture model, Wang et al found that some of the cancer-stromal hybrids could survive and led to colony formation in the co-culture, and these colonies featured with androgen-independent phenotypes [69]. It has been reported that coinjection of tumorigenic rat prostatic fibroblasts enhanced tumor formation of otherwise non-tumorigenic adjacent prostatic epithelial cells via paracrine signaling, leading to the formation of carcinosarcoma [70].…”
Section: Discussionmentioning
confidence: 99%